S23-342 Chimeric transcription factors for engineering exhaustion-resistant CAR-T and other cell therapies Stanford researchers have developed a strategy for generating chimeric transcription factors that enables exhaustion-resistant CAR-T cells and can be generalized to a wide range of cell therapies. Oliver Takacsi-Nagy Theodore Roth Ansuman Satpathy